Publications Database

Althaus M. et al. (2015)

Oxytocin enhances orienting to social information in a selective group of high-functioning male adults with autism spectrum disorder.

Neuropsychologia

December, 79 pp. 53-69.

Read Abstract (New Window)

Bildt A. A. D. et al. (2009)

Validity of the Children's Social Behavior Questionnaire (CSBQ) in children with intellectual disability: Comparing the CSBQ with ADI-R, ADOS, and clinical DSM-IV-TR classification.

Journal of Autism and Developmental Disorders

39(10), pp. 1464-1470.

Read Abstract (New Window)

Dinnissen M. et al. (2015)

Clinical and pharmacokinetic evaluation of risperidone for the management of autism spectrum disorder.

Expert Opinion on Drug Metabolism and Toxicology

January, 11(1), pp. 111-124.

Read Abstract (New Window)

Harfterkamp M. et al. (2012)

A randomized double-blind study of atomoxetine versus placebo for attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorder.

Journal of the American Academy of Child and Adolescent Psychiatry

5(7), pp. 733-741.

Read Abstract (New Window)

Harfterkamp M. et al. (2014)

Atomoxetine in autism spectrum disorder: no effects on social functioning; some beneficial effects on stereotyped behaviors, inappropriate speech, and fear of change.

Journal of Child and Adolescent Psychopharmacology

November, 24(9), pp. 481-485.

Read Abstract (New Window)

Harfterkamp M. et al. (2013)

Long-term treatment with atomoxetine for attention-deficit/hyperactivity disorder symptoms in children and adolescents with autism spectrum disorder: An open-label extension study.

Journal of Child and Adolescent Psychopharmacology

23(3), pp. 194-199.

Read Abstract (New Window)

Ly V. et al. (2017)

Elimination diets’ efficacy and mechanisms in attention deficit hyperactivity disorder and autism spectrum disorder.

European Child and Adolescent Psychiatry

February,

Read Full (New Window)

Meer L. A. v. d. et al. (2013)

A randomized, double-blind comparison of atomoxetine and placebo on response inhibition and interference control in children and adolescents with autism spectrum disorder and comorbid attention-deficit/hyperactivity disorder symptoms.

Journal of Clinical Psychopharmacology

December, 33(6), pp. 824-827.

Read Abstract (New Window)

Nijmeijer J. et al. (2008)

Attention-deficit/hyperactivity disorder and social dysfunctioning.

Clinical Psychology Review

28(4), pp. 692-708.

Read Abstract (New Window)

Troost P. et al. (2006)

Atomoxetine for attention-deficit/hyperactivity disorder symptoms in children with pervasive developmental disorders: a pilot study.

Journal of Child and Adolescent Psychopharmacology

pp. 611-619

Read Abstract (New Window)

Troost P. et al. (2005)

Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study.

Journal of the American Academy of Child and Adolescent Psychiatry

44(11), pp. 1137-1144

Read Abstract (New Window)